June 8, 2019 - TRIAL-IN Pharma

A breakthrough in cancer research: A drug for young people proved effective and prolongs life

Post author:NIR EREZ
Post published:June 8, 2019
Post category:Clinical Trials

A new drug called Entrectinib for the treatment of children and adults with cancer that has recurred or is resistant to treatment, including brain cancers About Entrectinib - Entectinib is…

Read more about the article An Approved Cancer Drug for Breast Cancer Is Now a Potential New Treatment Option for HER2-Amplified Advanced Salivary Gland Cancer

An Approved Cancer Drug for Breast Cancer Is Now a Potential New Treatment Option for HER2-Amplified Advanced Salivary Gland Cancer

Post author:NIR EREZ
Post published:June 8, 2019
Post category:Head and Neck Cancer

About “Kadcyla”, Ado-trastuzumab emtansine and HER2-Amplified Advanced Salivary Gland Cancer, SGC - Ado-trastuzumab emtansine, more commonly known as T-DM1 and sold under the trade name “Kadcyla”, is a HER2 targeted antibody-drug…